HAYWARD, Calif.–(BUSINESS WIRE)–Jan 21, 2013 – Impax Pharmaceuticals, a division of Impax Laboratories, Inc., announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the New Drug Application…
SYDNEY and BEDMINSTER, N.J., Jan. 16 2013 /PRNewswire/ — QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the steps necessary for approval of immediate release MoxDuo have been clarified with the United States Food and Drug…
QRxPharma and FDA Establish Path Forward for Resubmission Of Moxduo New Drug Application Read More »
SYDNEY and BEDMINSTER, N.J., Jan. 16 2013 /PRNewswire/ — QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the steps necessary for approval of immediate release MoxDuo have been clarified with the United States Food and Drug…
QRxPharma and FDA Establish Path Forward for Resubmission Of Moxduo New Drug Application Read More »
SYDNEY and BEDMINSTER, N.J., Jan. 16 2013 /PRNewswire/ — QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the steps necessary for approval of immediate release MoxDuo have been clarified with the United States Food and Drug…
QRxPharma and FDA Establish Path Forward for Resubmission Of Moxduo New Drug Application Read More »
SYDNEY and BEDMINSTER, N.J., Jan. 16 2013 /PRNewswire/ — QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the steps necessary for approval of immediate release MoxDuo have been clarified with the United States Food and Drug…
QRxPharma and FDA Establish Path Forward for Resubmission Of Moxduo New Drug Application Read More »
AvenCell Therapeutics announced that it raised $115 million in a Series B round. The company is developing CAR-T therapies that can be turned “on” or “off” with a goal to…
‘Switchable’ CAR-T startup raises $112 million Read More »
DUBLIN–(BUSINESS WIRE)–The "Global CAR-T Cell Therapy Market – Market Size, Forecasts, Trials, and Trends, 2024" report has been added to ResearchAndMarkets.com’s offering. T-cells form the backbone of CAR-T cell therapy. T-cells are the workhorses of our immune system and play a key role in directing the immune response and killing cells infected by pathogens. In CAR-T cell therapy, blood is drawn from the patient and the T-cells are separated out. In the laboratory, a disarmed virus is then
Minutes of the CAT meeting 22-24 May 2024
Minutes of the CAT meeting 22-24 May 2024 Read More »
**Refined Title: Innovative Sneezing Mechanism in Squirrels: Potential Implications for Biotech** In the intricate world of biotechnology, unexpected biological phenomena can sometimes lead to groundbreaking innovations. One such curiosity is the voluntary sneezing mechanism observed in a species of squirrel, recently highlighted in Nature’s archives. Understanding this unique biological feature could unveil new pathways for
Splendid squirrel sneezes at will Read More »
Telix unveils radiopharmaceutical spinoff Rhine Pharma following string of nuclear medicine acquisitions
fkansteiner
